Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Notch1 receptor is a single-pass transmembrane protein and canonical member of the Notch receptor family, functioning as a cell-surface receptor that mediates direct cell-cell communication essential for the regulation of cell fate decisions during embryonic and adult development. Notch1 is activated when neighboring cells present membrane-bound ligands (such as Jagged1, Jagged2, and DLL1), leading to a proteolytic cascade that releases the Notch1 intracellular domain (NICD). NICD translocates to the nucleus where it acts as a transcriptional coactivator with the CSL family of transcription factors and Mastermind-like (MAML) proteins to control target gene expression. Notch1 signaling controls key processes such as differentiation, proliferation, apoptosis, and maintenance of stem and progenitor cells, and dysregulation of this pathway is implicated in various cancers, cardiovascular diseases, and developmental syndromes.
Inhibition of proteolytic cleavage (e.g., γ-secretase inhibition to prevent activation), blockade of ligand-receptor interaction (antibodies), modulation of Notch transcriptional activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Notch1 receptor (NOTCH1).